Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dipeptidase 1 (DPEP1), also known as renal dipeptidase, is a membrane-bound glycoprotein enzyme primarily responsible for hydrolyzing dipeptides. It is most abundantly expressed in the kidney, particularly on the brush border of proximal tubular cells and peritubular capillaries. It functions as a homodimer and contains binuclear zinc ions critical for catalysis. Beyond peptide hydrolysis, DPEP1 also acts as an adhesion receptor facilitating neutrophil recruitment into inflamed tissues. Its activity impacts glutathione homeostasis, leukotriene processing, and can hydrolyze certain beta-lactam antibiotics.
Hydrolyzes various dipeptides via binuclear zinc ions at the active site. Also functions as an adhesion receptor promoting neutrophil recruitment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dipeptidase 1 (DPEP1).